Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details Narrative)

v3.7.0.1
Stockholders' Deficit (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 27, 2017
Jul. 13, 2016
Feb. 07, 2014
Jan. 03, 2014
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Dec. 31, 2013
Sold securities in a self-directed offering, aggregate amount         $ 289,000    
Warrants to purchase of common stock shares     6,276,960 3,321,600       14,446,777
Warrants term     5 years 5 years       5 years
Number of common stock shares sold     6,276,960   567,644      
Proceeds from sale of common stock     $ 3,923,100   $ 60,000      
Equity Purchase Agreement [Member] | Investor [Member]                
Number of shares issued   1,500,000            
Fair value of stock grant fully vested   $ 106,500            
Restricted Stock One [Member]                
Warrants to purchase of common stock shares 416,666       2,237,500   14,012,500  
Restricted common stock price per share $ 0.12       $ 0.08   $ 0.08  
Warrants term 5 years       5 years   5 years  
Restricted Stock Two [Member]                
Warrants to purchase of common stock shares         2,237,500   14,012,500  
Restricted common stock price per share         $ 0.12   $ 0.12  
Warrants term         5 years   5 years  
Restricted Stock Three [Member]                
Warrants to purchase of common stock shares         2,237,500   14,012,500  
Restricted common stock price per share         $ 0.16   $ 0.16  
Warrants term         5 years   5 years  
Self Directed Stock Issuance [Member]                
Sold securities in a self-directed offering, aggregate amount $ 50,000       $ 179,000   $ 1,121,000  
Issuance of stock per share $ 0.12       $ 0.08   $ 0.08  
Conversion stock, description Each unit consisted of 1 share of restricted common stock (416,666 shares) and a five-year warrant to purchase 1 share of restricted common stock (416,666 warrant shares) at $0.12 per share.       Each unit consisted of 1 share of restricted common stock (2,237,500 shares), a five-year warrant to purchase 1 share of restricted common stock (2,237,500 warrant shares) at $0.08 per share, a five-year warrant to purchase 1 share of restricted common stock (2,237,500 warrant shares) at $0.12 per share, and a five-year warrant to purchase 1 share of restricted common stock (2,237,500 warrant shares) at $0.16 per share.   Each unit consisted of 1 share of restricted common stock (14,012,500 shares), a five-year warrant to purchase 1 share of restricted common stock (14,012,500 warrant shares) at $0.08 per share, a five-year warrant to purchase 1 share of restricted common stock (14,012,500 warrant shares) at $0.12 per share, and a five-year warrant to purchase 1 share of restricted common stock (14,012,500 warrant shares) at $0.16 per share.